| Year |
Citation |
Score |
| 2010 |
Cramer NP, Best TK, Stoffel M, Siarey RJ, Galdzicki Z. GABAB-GIRK2-mediated signaling in Down syndrome. Advances in Pharmacology (San Diego, Calif.). 58: 397-426. PMID 20655490 DOI: 10.1016/S1054-3589(10)58015-3 |
0.679 |
|
| 2009 |
Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, Siarey RJ, Lensch MW, Park IH, Yoon SS, Minami T, Korenberg JR, Folkman J, Daley GQ, Aird WC, Galdzicki Z, et al. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature. 459: 1126-30. PMID 19458618 DOI: 10.1038/Nature08062 |
0.67 |
|
| 2008 |
Best TK, Cho-Clark M, Siarey RJ, Galdzicki Z. Speeding of miniature excitatory post-synaptic currents in Ts65Dn cultured hippocampal neurons. Neuroscience Letters. 438: 356-61. PMID 18490108 DOI: 10.1016/j.neulet.2008.04.039 |
0.71 |
|
| 2007 |
Olson LE, Roper RJ, Sengstaken CL, Peterson EA, Aquino V, Galdzicki Z, Siarey R, Pletnikov M, Moran TH, Reeves RH. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Human Molecular Genetics. 16: 774-82. PMID 17339268 DOI: 10.1093/Hmg/Ddm022 |
0.698 |
|
| 2007 |
Best TK, Siarey RJ, Galdzicki Z. Ts65Dn, a mouse model of Down syndrome, exhibits increased GABAB-induced potassium current. Journal of Neurophysiology. 97: 892-900. PMID 17093127 DOI: 10.1152/jn.00626.2006 |
0.703 |
|
| 2006 |
Siarey RJ, Kline-Burgess A, Cho M, Balbo A, Best TK, Harashima C, Klann E, Galdzicki Z. Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome. Journal of Neurochemistry. 98: 1266-77. PMID 16895585 DOI: 10.1111/J.1471-4159.2006.04238.X |
0.677 |
|
| 2006 |
Harashima C, Jacobowitz DM, Stoffel M, Chakrabarti L, Haydar TF, Siarey RJ, Galdzicki Z. Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. Cellular and Molecular Neurobiology. 26: 719-34. PMID 16783527 DOI: 10.1007/S10571-006-9066-4 |
0.699 |
|
| 2006 |
Harashima C, Jacobowitz DM, Witta J, Borke RC, Best TK, Siarey RJ, Galdzicki Z. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. The Journal of Comparative Neurology. 494: 815-33. PMID 16374808 DOI: 10.1002/Cne.20844 |
0.711 |
|
| 2005 |
Siarey RJ, Villar AJ, Epstein CJ, Galdzicki Z. Abnormal synaptic plasticity in the Ts1Cje segmental trisomy 16 mouse model of Down syndrome. Neuropharmacology. 49: 122-8. PMID 15992587 DOI: 10.1016/J.Neuropharm.2005.02.012 |
0.713 |
|
| 2003 |
Galdzicki Z, Siarey RJ. Understanding mental retardation in Down's syndrome using trisomy 16 mouse models. Genes, Brain, and Behavior. 2: 167-78. PMID 12931790 DOI: 10.1034/j.1601-183X.2003.00024.x |
0.716 |
|
| 2001 |
Galdzicki Z, Siarey R, Pearce R, Stoll J, Rapoport SI. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models. Brain Research. Brain Research Reviews. 35: 115-45. PMID 11336779 DOI: 10.1016/S0926-6410(00)00074-4 |
0.733 |
|
| 2001 |
Klein RC, Siarey RJ, Caruso A, Rapoport SI, Castellino FJ, Galdzicki Z. Increased expression of NR2A subunit does not alter NMDA-evoked responses in cultured fetal trisomy 16 mouse hippocampal neurons. Journal of Neurochemistry. 76: 1663-9. PMID 11259484 DOI: 10.1046/J.1471-4159.2001.00170.X |
0.678 |
|
| 2000 |
Shetty HU, Siarey RJ, Galdzicki Z, Stoll J, Rapoport SI. Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues. Neurochemical Research. 25: 431-5. PMID 10823574 DOI: 10.1023/A:1007592006005 |
0.666 |
|
| 1999 |
Siarey RJ, Carlson EJ, Epstein CJ, Balbo A, Rapoport SI, Galdzicki Z. Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome. Neuropharmacology. 38: 1917-20. PMID 10608287 DOI: 10.1016/S0028-3908(99)00083-0 |
0.686 |
|
| 1997 |
Siarey RJ, Stoll J, Rapoport SI, Galdzicki Z. Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome. Neuropharmacology. 36: 1549-54. PMID 9517425 DOI: 10.1016/S0028-3908(97)00157-3 |
0.72 |
|
| 1997 |
Siarey RJ, Coan EJ, Rapoport SI, Galdzicki Z. Responses to NMDA in cultured hippocampal neurons from trisomy 16 embryonic mice. Neuroscience Letters. 232: 131-4. PMID 9310297 DOI: 10.1016/S0304-3940(97)00581-8 |
0.672 |
|
| Show low-probability matches. |